1. Home
  2. WAFU vs OGEN Comparison

WAFU vs OGEN Comparison

Compare WAFU & OGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Wah Fu Education Group Limited

WAFU

Wah Fu Education Group Limited

N/A

Current Price

$1.68

Market Cap

7.4M

Sector

Real Estate

ML Signal

N/A

Logo Oragenics Inc.

OGEN

Oragenics Inc.

HOLD

Current Price

$0.78

Market Cap

3.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WAFU
OGEN
Founded
1999
1996
Country
China
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.4M
3.6M
IPO Year
2017
2010

Fundamental Metrics

Financial Performance
Metric
WAFU
OGEN
Price
$1.68
$0.78
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
2.9K
562.3K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.22
$0.11
52 Week High
$2.17
$9.16

Technical Indicators

Market Signals
Indicator
WAFU
OGEN
Relative Strength Index (RSI) 47.96 46.12
Support Level $1.63 $0.78
Resistance Level $1.69 $0.90
Average True Range (ATR) 0.04 0.10
MACD -0.00 -0.00
Stochastic Oscillator 17.39 7.76

Price Performance

Historical Comparison
WAFU
OGEN

About WAFU Wah Fu Education Group Limited

Wah Fu Education Group Ltd is involved in providing online exam preparation services and related technology solutions, and also produces online training course materials in China. It develops online educational materials that are offered through the cloud and that can be used for a wide range of purposes, such as standard examination preparation, professional training, and interactive programs for educational purposes other than exam preparation. Its segments are Online Education Services and Technological Development and Operation Service. The company generates maximum revenue from the Online Education Services segment.

About OGEN Oragenics Inc.

Oragenics Inc is engaged in the research and development of nasal delivery pharmaceutical medications in neurology and fighting infectious diseases. The company's product ONP-002 is a fully synthetic, non-naturally occurring neurosteroid, is lipophilic, and can cross the blood-brain barrier to rapidly reduce swelling, oxidative stress and inflammation while restoring proper blood flow through gene amplification. The Company operates in one reportable segment, which includes activities related to advancing the development of its concussion drug, ONP-002.

Share on Social Networks: